Abbvie reported $6.29B in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 2469M 317M
Abbvie ABBV:US $ 6290M 282M
Acceleron Pharma XLRN:US $ -63.51M 0.05M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Chemocentryx CCXI:US $ -39.21M 9.5M
Eisai 4523:JP Y 55783M 61588M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Endo International Ordinary Shares ENDP:US $ 181.61M 22.56M
GlaxoSmithKline GSK:LN 1482M 225M
Infinity Pharmaceuticals INFI:US $ -11.27M 0.67M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Johnson & Johnson JNJ:US $ 7776M 515M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novartis NOVN:VX SF 4424M 620M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sanofi SAN:FP € 2180M 376M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
United Therapeutics UTHR:US $ 216.5M 184M